Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction

K S Rabindranath1, N R Anderson, R Gama

  • 1Department of Medicine, New Cross Hospital, Wolverhampton, West Midlands, UK.

Insights

The new Sheffield table and modified Joint British Societies (JBS) coronary heart disease (CHD) risk charts demonstrate high accuracy in primary care. Both tools are reliable for assessing patient risk, allowing clinicians to choose based on preference.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Health Informatics

Background:

  • Coronary heart disease (CHD) risk assessment guides management of borderline hypertension and hypercholesterolemia.
  • Traditional CHD risk prediction relies on Framingham equations, often simplified by tools like the Sheffield table and Joint British Societies (JBS) chart.
  • Simplifications in these charts, such as dichotomizing blood pressure or approximating age, may impact diagnostic accuracy.

Purpose of the Study:

  • To evaluate and compare the diagnostic performance of the new Sheffield table and the modified JBS chart.
  • To assess these tools against individualized, laboratory-based CHD risk calculations.

Main Methods:

  • Diagnostic performance evaluation of two CHD risk assessment tools.
  • Comparison against a laboratory-based CHD risk calculation.
  • Study conducted on 1102 subjects in a primary care setting.

Main Results:

  • Both the new Sheffield table and modified JBS chart exhibited high diagnostic accuracy, with similar sensitivity and specificity at 10-year CHD risk thresholds of 15% and 30%.
  • The modified JBS chart offers a graded risk display, potentially advantageous over the Sheffield table's threshold identification.
  • The Sheffield table uniquely functions as a screening tool for cholesterol measurement.

Conclusions:

  • The new Sheffield table and modified JBS chart are validated for primary care use, with diagnostic accuracy unaffected by approximations in age and blood pressure.
  • Clinicians are advised to select the risk assessment tool they are most comfortable using.
  • Both tools provide reliable CHD risk assessment in primary care settings.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...